Clinical Trail of SARS-CoV-2 Bivalent mRNA Vaccine (LVRNA021) in Participants Aged 18 Years and Older
Clinical trial NCT05812014 · UNKNOWN
Trial details
- NCT number
- NCT05812014
- Sponsor
- AIM Vaccine Co., Ltd.
- Status
- UNKNOWN
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2023-03-25
- Primary completion
- 2024-03-01
- Enrollment
- 9800
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.